BRCA1 Antibody

ProSci
Product Code: PSI-79-213
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-79-213-0.1mg0.1mg£488.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Storage:
Store antibody at -20˚C for up to one year.

Images

1 / 2
Western blot analysis of lysed extracts from HT29 cells untreated or treated with Anisomycin using BRCA1 (Phospho-Ser1423).
2 / 2
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using BRCA1 (Phospho-Ser1423).

Western blot analysis of lysed extracts from HT29 cells untreated or treated with Anisomycin using BRCA1 (Phospho-Ser1423).
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using BRCA1 (Phospho-Ser1423).

Further Information

Additional Names:
IRIS, PSCP, BRCAI, BRCC1, PNCA4, RNF53, BROVCA1, PPP1R53, ERYF1, GF1
Application Note:
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100
Background:
The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Acts by mediating ubiquitin E3 ligase activity that is required for its tumor suppressor function. Plays a central role in DNA repair by facilitating cellular response to DNA repair. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation
Background References:
  • Kim ST, et al. (2002) Genes Dev; 16 (5): 560-570Arlt MF, et al. (2004) Mol Cell Biol; 24 (15): 6701-6709Zhang J, et al. (2004) Mol Cell Biol; 24 (2): 708-718Greenberg RA, et al. (2006) Genes Dev; 20 (1): 34-46Tibbetts RS, et al. (2000) Genes Dev; 14 (23): 2989-3002
Buffer:
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
BRCA1 (Phospho-Ser1423) antibody was raised against a peptide sequence around phosphorylation site of serine 1423 (H-G-S (p) -Q-P) derived from Human BRCA1.
Modifications:
Phospho-Specific
NCBI Gene ID #:
672
NCBI Official Name:
breast cancer 1, early onset
NCBI Official Symbol:
BRCA1
NCBI Organism:
Homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
220 kDa
Protein Accession #:
NP_009225.1
Protein GI Number:
6552299
Purification:
Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
Research Area:
Phospho-Specific,Cell Cycle
SPECIFICITY:
This antibody detects endogenous level of BRCA1 only when phosphorylated at serine 1423.
Swissprot #:
P38398